EPISODE · Oct 25, 2023 · 1H 11M
TechBio Founders #24: Using AI and multi-omics to predict the efficacy of immunotherapies with Vadim Nazarov, CEO at ImmunoMind
from Next Sequence · host Vadim Nazarov, Loretta TIOIELA
ImmunoMind is a UC Berkeley SkyDeck alumnus company. ImmunoMind helps biotech companies understand crucial drug-human interactions, and transform the biodata chaos into more effective immunotherapies.
NOW PLAYING
TechBio Founders #24: Using AI and multi-omics to predict the efficacy of immunotherapies with Vadim Nazarov, CEO at ImmunoMind
0:00
1:11:51
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Next Sequence?
This episode is 1 hour and 11 minutes long.
When was this Next Sequence episode published?
This episode was published on October 25, 2023.
What is this episode about?
ImmunoMind is a UC Berkeley SkyDeck alumnus company. ImmunoMind helps biotech companies understand crucial drug-human interactions, and transform the biodata chaos into more effective immunotherapies.
Can I download this Next Sequence episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!